0001437749-23-027674.txt : 20231004 0001437749-23-027674.hdr.sgml : 20231004 20231004170241 ACCESSION NUMBER: 0001437749-23-027674 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231004 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001742927 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38634 FILM NUMBER: 231308772 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4085018881 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: Tenzing Acquisition Corp. DATE OF NAME CHANGE: 20180606 8-K 1 rvph20231002_8k.htm FORM 8-K rvph20231002_8k.htm
false 0001742927 0001742927 2023-10-04 2023-10-04 0001742927 rvph:CommonStockParValue00001PerShareCustomMember 2023-10-04 2023-10-04 0001742927 rvph:WarrantsToPurchaseOneShareOfCommonStockCustomMember 2023-10-04 2023-10-04
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
 
FORM 8-K
   
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 4, 2023
 
REVIVA PHARMACEUTICALS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
001-38634
85-4306526
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 
19925 Stevens Creek Blvd., Suite 100, Cupertino, CA
  
95014
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (408) 501-8881
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
  
RVPH
  
Nasdaq Capital Market
Warrants to purchase one share of Common Stock
  
RVPHW
  
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 4.01. Changes in Registrant's Certifying Accountant.
 
As previously disclosed by Reviva Pharmaceutical Holdings, Inc. (the “Company”) in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on July 24, 2023, the Company was informed on July 18, 2023 by Armanino LLP (“Armanino”), the Company’s current independent registered public accounting firm, that Armanino would decline to stand for re-appointment after completion of Armanino’s review procedures on the unaudited financial statements of the Company as of and for the three and nine months ended September 30, 2023. Armanino advised the Company that its decision not to stand for reappointment was due to Armanino’s transition away from providing financial statement audit services to public companies. In light of Armanino’s determination, the Audit Committee of the Company’s Board of Directors initiated a process to select a new accounting firm to serve as the Company’s independent registered public accountant.
 
On October 4, 2023, the Audit Committee of the Company’s Board of Directors appointed Moss Adams LLP (“Moss Adams”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2023. Moss Adams’ engagement, which commences with the audit of the Company’s financial statements for the fiscal year ending December 31, 2023, will not affect Armanino’s review of the Company’s unaudited financial statements for the third quarter of 2023, which Armanino remains engaged to complete. Armanino’s engagement and tenure as the Company’s independent registered public accounting firm will end upon completion of Armanino’s review procedures on the unaudited financial statements of the Company as of and for the three and nine months ending September 30, 2023 and the filing with the SEC of the Company’s Quarterly Report on Form 10-Q for such period.
 
During the Company’s two most recent fiscal years ended December 31, 2021 and 2022, and the subsequent interim period through October 4, 2023, the date of Moss Adams’ engagement, neither the Company nor anyone acting on its behalf consulted with Moss Adams regarding either of the following: (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Moss Adams concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a disagreement, as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions, or a “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.
 
Armanino’s audit reports on the Company's consolidated financial statements as of and for the years ended December 31, 2021 and 2022 did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except the audit report for the fiscal year ended December 31, 2022 contained a “going concern” explanatory paragraph. During the years ended December 31, 2021 and 2022, and during the subsequent interim period through October 4, 2023, there were no (a) disagreements with Armanino on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Armanino's satisfaction, would have caused Armanino to make reference to the subject matter thereof in connection with its reports for such periods; or (b) reportable events, as described under Item 304(a)(1)(v) of Regulation S-K.
 
In accordance with Item 304(a)(3) of Regulation S-K, the Company provided Armanino with a copy of the disclosures it is making in this Current Report on Form 8-K and requested from Armanino a letter addressed to the Securities and Exchange Commission indicating whether it agrees with such disclosures. A copy of Armanino’s letter dated October 4, 2023 is attached as Exhibit 16.1 hereto.
 
 
 
 
Item 9.01: Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
  
Description
     
16.1
  
     
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
REVIVA PHARMACEUTICALS HOLDINGS, INC.
  
       
       
Date: October 4, 2023
By:
/s/ Narayan Prabhu
  
   
Narayan Prabhu
  
   
Chief Financial Officer
  
 
 
 
 EX-16.1 2 ex_575780.htm EXHIBIT 16.1 ex_575780.htm

 

Exhibit 16.1

 

October 4, 2023

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Commissioners:

 

We have read Item 4.01 of the Current Report on Form 8-K of Reviva Pharmaceuticals Holdings, Inc. dated October 4, 2023, which we understand will be filed with the Securities and Exchange Commission, and we agree with the statements concerning our firm contained in such Form 8-K. We have no basis to agree or disagree with other statements of the registrant contained therein.

 

Very truly yours,

 

/s/ Armanino LLP

 

Armanino LLP

San Ramon, California

 

 

 
 EX-101.SCH 3 rvph-20231004.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 rvph-20231004_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 rvph-20231004_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Entity, Ex Transition Period Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] CommonStockParValue00001PerShare Custom [Member] WarrantsToPurchaseOneShareOfCommonStock Custom [Member] EX-101.PRE 6 rvph-20231004_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Oct. 04, 2023
Document Information [Line Items]  
Entity, Registrant Name REVIVA PHARMACEUTICALS HOLDINGS, INC.
Document, Type 8-K
Document, Period End Date Oct. 04, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38634
Entity, Tax Identification Number 85-4306526
Entity, Address, Address Line One 19925 Stevens Creek Blvd., Suite 100
Entity, Address, City or Town Cupertino
Entity, Address, State or Province CA
Entity, Address, Postal Zip Code 95014
City Area Code 408
Local Phone Number 501-8881
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company true
Entity, Ex Transition Period false
Amendment Flag false
Entity, Central Index Key 0001742927
CommonStockParValue00001PerShare Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol RVPH
Security Exchange Name NASDAQ
WarrantsToPurchaseOneShareOfCommonStock Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants to purchase one share of Common Stock
Trading Symbol RVPHW
Security Exchange Name NASDAQ
XML 8 rvph20231002_8k_htm.xml IDEA: XBRL DOCUMENT 0001742927 2023-10-04 2023-10-04 0001742927 rvph:CommonStockParValue00001PerShareCustomMember 2023-10-04 2023-10-04 0001742927 rvph:WarrantsToPurchaseOneShareOfCommonStockCustomMember 2023-10-04 2023-10-04 false 0001742927 8-K 2023-10-04 REVIVA PHARMACEUTICALS HOLDINGS, INC. DE 001-38634 85-4306526 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 408 501-8881 false false false false Common Stock, par value $0.0001 per share RVPH NASDAQ Warrants to purchase one share of Common Stock RVPHW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 3 23 1 false 2 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.rvph.com/20231004/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports rvph-20231004.xsd rvph-20231004_def.xml rvph-20231004_lab.xml rvph-20231004_pre.xml rvph20231002_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "rvph20231002_8k.htm": { "nsprefix": "rvph", "nsuri": "http://www.rvph.com/20231004", "dts": { "schema": { "local": [ "rvph-20231004.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "rvph-20231004_def.xml" ] }, "labelLink": { "local": [ "rvph-20231004_lab.xml" ] }, "presentationLink": { "local": [ "rvph-20231004_pre.xml" ] }, "inline": { "local": [ "rvph20231002_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://www.rvph.com/20231004/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "rvph20231002_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "rvph20231002_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "rvph_CommonStockParValue00001PerShareCustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.rvph.com/20231004", "localname": "CommonStockParValue00001PerShareCustomMember", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "CommonStockParValue00001PerShare Custom [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "rvph_WarrantsToPurchaseOneShareOfCommonStockCustomMember": { "xbrltype": "domainItemType", "nsuri": "http://www.rvph.com/20231004", "localname": "WarrantsToPurchaseOneShareOfCommonStockCustomMember", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "WarrantsToPurchaseOneShareOfCommonStock Custom [Member]" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.rvph.com/20231004/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001437749-23-027674-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-027674-xbrl.zip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end